Pimobendan Tablets Brouwer – 2.5 mg (For Dogs)
Therapeutic Class: Cardiac Support / Veterinary Medication
Form: Palatable Tablets – Box of 20
Active Ingredient: Pimobendan 2.5 mg
Pimobendan Tablets Brouwer are formulated for the treatment of congestive heart failure in dogs caused by dilated cardiomyopathy (DCM) or chronic valvular disease (CVD). This medication improves cardiac performance by increasing the strength of heart contractions and promoting balanced vasodilation, leading to better blood flow and reduced cardiac workload.
Key Benefits
Supports heart function: Enhances myocardial contraction efficiency without raising oxygen consumption.
Reduces cardiac stress: Vasodilator properties help decrease vascular resistance.
Palatable and easy to administer: Dogs readily accept the flavored tablet.
Clinically tested: Developed by Laboratorios Brouwer, trusted in veterinary cardiology.
Dosage & Administration
Administer 0.2–0.6 mg/kg/day, divided into two doses given approximately every 12 hours or as directed by your veterinarian.
For best results, give one hour before feeding.
Precautions
For veterinary use only.
Not suitable for cats or dogs with hypertrophic cardiomyopathy or serious arrhythmias.
Always follow your veterinarian’s prescription.
Manufacturer
Laboratorios Brouwer S.A.
Origin: Argentina
Pack Size: 20 palatable tablets (2.5 mg each)
For dogs living with heart failure, Pimobendan Tablets Brouwer deliver trusted, effective cardiac support to improve quality of life and maintain vitality — under professional veterinary supervision.